MASSARO, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 1.480
EU - Europa 426
AS - Asia 138
AF - Africa 13
SA - Sud America 9
Totale 2.066
Nazione #
US - Stati Uniti d'America 1.472
IT - Italia 141
SE - Svezia 119
IN - India 71
CN - Cina 47
FI - Finlandia 44
GB - Regno Unito 20
DE - Germania 19
SG - Singapore 14
BG - Bulgaria 11
FR - Francia 11
IE - Irlanda 11
UA - Ucraina 11
RO - Romania 8
TG - Togo 8
CA - Canada 7
NL - Olanda 7
BE - Belgio 5
CH - Svizzera 5
PL - Polonia 5
AR - Argentina 4
HU - Ungheria 4
IL - Israele 3
BR - Brasile 2
CL - Cile 2
RS - Serbia 2
SC - Seychelles 2
AT - Austria 1
AZ - Azerbaigian 1
CI - Costa d'Avorio 1
CO - Colombia 1
ES - Italia 1
GH - Ghana 1
GL - Groenlandia 1
KZ - Kazakistan 1
SI - Slovenia 1
TM - Turkmenistan 1
ZA - Sudafrica 1
Totale 2.066
Città #
Fairfield 249
Chandler 148
Woodbridge 123
Ashburn 103
Seattle 85
Dearborn 82
Houston 79
Wilmington 79
Cambridge 76
Rome 46
Princeton 42
Ann Arbor 39
Plano 34
San Paolo di Civitate 31
Lawrence 26
Beijing 22
Helsinki 19
Boston 18
Des Moines 16
Millbury 16
San Diego 14
Dublin 11
Sofia 11
Andover 10
New York 10
Southend 9
Lomé 8
Norwalk 8
Nanjing 7
Phoenix 7
Brussels 5
Grafing 5
Kunming 5
Los Angeles 5
Monterotondo 5
Singapore 5
Budapest 4
Bühl 4
Federal 4
Fremont 4
Guangzhou 4
Milan 4
Toronto 4
Warsaw 4
Bern 3
Dallas 3
Jacksonville 3
Paris 3
Tel Aviv 3
Auburn Hills 2
Belgrade 2
Boardman 2
Bremen 2
Centro 2
Chicago 2
Delft 2
Edinburgh 2
Falls Church 2
Genova 2
Hanover 2
Indiana 2
Nanning 2
Pomezia 2
San Mateo 2
Spinea 2
Turin 2
Zurich 2
Abidjan 1
Ashgabat 1
Baku 1
Barcelona 1
Bogotá 1
Chennai 1
Civitanova Marche 1
Florence 1
Frankfurt am Main 1
Halle 1
Harfleur 1
Hefei 1
Hyderabad 1
Islington 1
Jinan 1
Jönköping 1
Kamampa 1
Lachine 1
Las Vegas 1
Leawood 1
London 1
Mahé 1
Muizenberg 1
Nanchang 1
Napoli 1
Nettuno 1
Nuuk 1
Ottawa 1
Polska 1
Provo 1
Quzhou 1
Québec 1
Redmond 1
Totale 1.574
Nome #
Ultrasonographic Evaluation of Resistive Index and Renal Artery Stenosis in Patients with Anti-phospholipid Syndrome: Two Distinct Mechanisms? 100
Atypical presentation of anaplastic large T-cell lymphoma mimicking an articular relapse of rheumatoid arthritis in a patient treated with etanercept. A case report and literature review 88
Cognitive dysfunction improves in systemic lupus erythematosus: Results of a 10 years prospective study 85
Evaluation of the Patient Acceptable Symptom State (PASS) in Italian Patients Affected by Systemic Lupus Erythematosus: Association with Disease Activity Indices 82
The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: Results from a monocentric cohort 81
Anti-carbamylated protein antibodies in systemic lupus erythematosus patients with articular involvement 80
The role of dietary sodium intake on the modulation of T helper 17 cells and regulatory T cells in patients with rheumatoid arthritis and systemic lupus erythematosus 75
Prediction of chronic damage in systemic lupus erythematosus by using machine-learning models 74
Joint involvement in systemic lupus erythematosus: From pathogenesis to clinical assessment 74
Association between Staphylococcus aureus nasal carriage and disease phenotype in patients affected by systemic lupus erythematosus 74
Mycophenolate mofetil in systemic lupus erythematosus: results from a retrospective study in a large monocentric cohort and review of the literature. 73
Anti-carbamylated protein antibodies as a new biomarker of erosive joint damage in systemic lupus erythematosus 73
Systemic Lupus Erythematosus with and without Anti-dsDNA Antibodies: Analysis from a Large Monocentric Cohort 71
Assessment of disease activity in Systemic Lupus Erythematosus: Lights and shadows 69
The Role of Posttranslational Protein Modifications in Rheumatological Diseases: Focus on Rheumatoid Arthritis 68
Validation of a disease-specific health-related quality of life measure in adult Italian patients with systemic lupus erythematosus: LupusQoL-IT. 67
Longterm outcome of patients with primary antiphospholipid syndrome: A retrospective multicenter study 66
The Role of Disease Activity Score 28 in the Evaluation of Articular Involvement in Systemic Lupus Erythematosus. 64
Joint involvement in patients affected by systemic lupus erythematosus: application of the swollen to tender joint count ratio 60
Rituximab infusion-related adverse event rates are lower in patients with systemic lupus erythematosus than in those with rheumatoid arthritis. 59
Flare, Persistently Active Disease, and Serologically Active Clinically Quiescent Disease in Systemic Lupus Erythematosus: A 2-Year Follow-Up Study 57
Ultrasonographic Evaluation of Renal Resistive Index in Patients with Lupus Nephritis: Correlation with Histologic Findings. 56
Biological therapies in rheumatic diseases 55
Ultrasound evaluation of hand, wrist and foot joint synovitis in systemic lupus erythematosus. 55
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management 49
Correction: Biomarkers of erosive arthritis in systemic lupus erythematosus: Application of machine learning models (PLoS ONE (2018) 13: 12 (e0207926) DOI: 10.1371/journal.pone.0207926) 49
Acne indotta da micofenolato mofetile in pazienti affetti da lupus eritematoso sistemico: uno studio retrospettivo. 48
B lymphocyte stimulator modulates number and function of endothelial progenitor cells in systemic lupus erythematosus 46
Jaccoud's arthropathy in systemic lupus erythematosus: clinical, laboratory and ultrasonographic features 43
STUDIO PROSPETTICO MONOCENTRICO PER LA VALUTAZIONE DELLO STATO DI SALUTE MEDIANTE ‘‘PATIENT ACCEPTABLE SYMPTOM STATE’’ (PASS) IN PAZIENTI AFFETTI DA LUPUS ERITEMATOSO SISTEMICO: CORRELAZIONE GLI INDICI DI ATTIVITÀ DI MALATTIA 39
Pragmatic language dysfunction in systemic lupus erythematosus patients: Results from a single center Italian study 39
CORRELAZIONE FRA CLASSE ISTOLOGICA E INDICE DI ESISTENZA RENALE NEI PAZIENTI CON NEFRITE LUPICA 31
PREVALENZA DELLO STAFILOCOCCO AUREO NASALE IN PAZIENTI AFFETTI DA LUPUS ERITEMATOSO SISTEMICO 27
VALUTAZIONE DEL COINVOLGIMENTO DELLE ARTICOLAZIONI METATARSOFALANGEE IN PAZIENTI AFFETTI DA LUPUS ERITEMATOSO SISTEMICO: UNO STUDIO ULTRASONOGRAFICO 27
null 22
Mycophenolate mofetil-induced acne in systemic lupus erythematosus. 13
Neurocognitive dysfunction in systemic lupus erythematosus: association with antiphospholipids antibodies, disease activity and chronic damage 12
Increased eryptosis in patients with primary antiphospholipid syndrome (APS): a new actor in the pathogenesis of APS 10
Totale 2.161
Categoria #
all - tutte 6.095
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.095


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019170 0 0 0 0 0 0 0 0 0 0 101 69
2019/2020534 76 16 4 20 51 106 89 58 54 30 18 12
2020/2021148 12 20 7 5 5 7 1 15 39 22 12 3
2021/2022427 6 26 43 24 56 20 13 40 21 33 74 71
2022/2023492 76 112 34 48 50 67 3 36 29 5 28 4
2023/2024144 16 27 7 9 12 21 5 23 1 21 2 0
Totale 2.161